Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

A review study on Guillain barre syndrome

Breadcrumb

  • Home
  • A review study on Guillain barre syndrome

Bhavya Reddy Datla 1, *, Viharika Nemalikanti 1, Moshe Nayak Bhukya 1, Sandeep Kurakula 1 and Srinivasa Babu Puttagunta 2

1 Department of Pharmacy Practice, Vignan Pharmacy College (Autonomous), Vadlamudi, Guntur, Andhra Pradesh, India.
2 Department of Pharmaceutics, Vignan Pharmacy College (Autonomous), Vadlamudi, Guntur, Andhra Pradesh, India.

Review Article
 
World Journal of Biology Pharmacy and Health Sciences, 2024, 20(03), 085–093.
Article DOI: 10.30574/wjbphs.2024.20.3.0947
DOI url: https://doi.org/10.30574/wjbphs.2024.20.3.0947

Received on 18 October 2024; revised on 02 December 2024; accepted on 05 December 2024

Acute immune-mediated peripheral nerve system dysfunction known as Guillain-Barre Syndrome (GBS) is typified by rapidly worsening muscle weakness, which frequently begins in the lower limbs and can eventually result in paralysis. It is typically brought on by an infectious event, most often a bacterial or viral infection, with Campylobacter jejuni being the most often linked harmful organism. According to epidemiology, there are 1-2 instances of GBS for every 100,000 people each year, with a small male predominance and greater frequency in adults over 50. Nerve conduction investigations and cerebrospinal fluid analysis demonstrating albumin cytological separation complement the largely clinical diagnosis.

Autoimmune Neurological Disorder; Peripheral Nerve Damage; Demyelination; Immune-mediated Nerve Injury; Plasma Exchange (PE); Intravenous Immunoglobulin (IVIg).

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2024-0947.pdf

Preview Article PDF

Bhavya Reddy Datla, Viharika Nemalikanti, Moshe Nayak Bhukya, Sandeep Kurakula and Srinivasa Babu Puttagunta. A review study on Guillain barre syndrome. World Journal of Biology Pharmacy and Health Sciences, 2024, 20(03), 085–093. Article DOI: https://doi.org/10.30574/wjbphs.2024.20.3.0947

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution